{"id":"https://openalex.org/W2109769875","doi":"https://doi.org/10.1111/jdv.12629","title":"Lack of effect of the glucagon\u2010like peptide\u20101 receptor agonist liraglutide on psoriasis in glucose\u2010tolerant patients \u2013 a randomized placebo\u2010controlled trial","display_name":"Lack of effect of the glucagon\u2010like peptide\u20101 receptor agonist liraglutide on psoriasis in glucose\u2010tolerant patients \u2013 a randomized placebo\u2010controlled trial","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-20","ids":{"openalex":"https://openalex.org/W2109769875","doi":"https://doi.org/10.1111/jdv.12629","mag":"2109769875","pmid":"https://pubmed.ncbi.nlm.nih.gov/25139195"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.12629","doi":"https://doi.org/10.1111/jdv.12629","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jdv.12629","pdf_url":null,"source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109769875"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009338195","display_name":"Annesofie Faurschou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. Faurschou","raw_affiliation_strings":["Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]},{"raw_affiliation_string":"Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011272661","display_name":"Mette Gyldenl\u00f8ve","orcid":"https://orcid.org/0000-0001-6156-6081","observed_orcids":["https://orcid.org/0000-0001-6156-6081"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Gyldenl\u00f8ve","raw_affiliation_strings":["Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":null,"display_name":"U. Rohde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"U. Rohde","raw_affiliation_strings":["Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015006218","display_name":"Jacob Pontoppidan Thyssen","orcid":"https://orcid.org/0000-0003-3770-1743","observed_orcids":["https://orcid.org/0000-0003-3770-1743"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.P. Thyssen","raw_affiliation_strings":["Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077648441","display_name":"Claus Otto Carl Zachariae","orcid":"https://orcid.org/0000-0001-5506-1319","observed_orcids":["https://orcid.org/0000-0001-5506-1319"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Zachariae","raw_affiliation_strings":["Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009118689","display_name":"Lone Skov","orcid":"https://orcid.org/0000-0002-4784-9680","observed_orcids":["https://orcid.org/0000-0002-4784-9680"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Skov","raw_affiliation_strings":["Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079352451","display_name":"Filip Krag Knop","orcid":"https://orcid.org/0000-0002-2495-5034","observed_orcids":["https://orcid.org/0000-0002-2495-5034"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F.K. Knop","raw_affiliation_strings":["Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004120950","display_name":"Tina Vilsb\u00f8ll","orcid":"https://orcid.org/0000-0002-0456-6787","observed_orcids":["https://orcid.org/0000-0002-0456-6787"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Vilsb\u00f8ll","raw_affiliation_strings":["Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Division, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009338195"],"corresponding_institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802582725"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":0.9716,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.7145939,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"29","issue":"3","first_page":"555","last_page":"559"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9750000238418579},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9520000219345093},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.7369999885559082},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pasi","display_name":"PASI","score":0.6740000247955322},{"id":"https://openalex.org/keywords/dermatology-life-quality-index","display_name":"Dermatology Life Quality Index","score":0.7950000166893005},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9860000014305115},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.597000002861023},{"id":"https://openalex.org/keywords/type-2-diabetes-comorbidity","display_name":"type 2 diabetes comorbidity","score":0.6990000009536743},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9610228538513184},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.955920934677124},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6401711106300354},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6348490715026855},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6191710829734802},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5879955291748047},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5050225853919983},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5021471977233887},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4467073082923889},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4348571300506592},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4287252426147461},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42201513051986694},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4156954884529114},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3202449679374695},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2872956395149231},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.20005294680595398},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.12534302473068237},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.08352100849151611},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/jdv.12629","doi":"https://doi.org/10.1111/jdv.12629","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jdv.12629","pdf_url":null,"source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmid:25139195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25139195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/f8478d1b-397f-4dfb-8e99-496ed89779ff","doi":null,"is_oa":false,"landing_page_url":"https://curis.ku.dk/portal/da/publications/lack-of-effect-of-the-glucagonlike-peptide1-receptor-agonist-liraglutide-on-psoriasis-in-glucosetolerant-patients--a-randomized-placebocontrolled-trial(f8478d1b-397f-4dfb-8e99-496ed89779ff).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Faurschou, A, Gyldenl\u00f8ve, M, Rohde, U, Thyssen, J P, Zachariae, C, Skov, L, Knop, F K & Vilsb\u00f8ll, T 2015, 'Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients \u2013 a randomized placebo-controlled trial', Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 3, pp. 555-559. https://doi.org/10.1111/jdv.12629","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2790715585","display_name":null,"funder_award_id":"NNF12OC1015904","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"}],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320323742","display_name":"Kongelig Hofbuntmager Aage Bangs Fond","ror":"https://ror.org/02rytd882"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1508573927","https://openalex.org/W1599017652","https://openalex.org/W1896914803","https://openalex.org/W1991748889","https://openalex.org/W1997332398","https://openalex.org/W2000976083","https://openalex.org/W2005662589","https://openalex.org/W2009205987","https://openalex.org/W2013976776","https://openalex.org/W2031980643","https://openalex.org/W2036909990","https://openalex.org/W2040745950","https://openalex.org/W2050489626","https://openalex.org/W2067314875","https://openalex.org/W2068393876","https://openalex.org/W2076276438","https://openalex.org/W2090360729","https://openalex.org/W2109867746","https://openalex.org/W2118509723","https://openalex.org/W2125563242","https://openalex.org/W2129730863","https://openalex.org/W2131873059","https://openalex.org/W2135442487","https://openalex.org/W2150913805","https://openalex.org/W2152835319","https://openalex.org/W2154909919"],"related_works":["https://openalex.org/W2076276438","https://openalex.org/W2919334767","https://openalex.org/W3159792324","https://openalex.org/W3088168236","https://openalex.org/W1896914803","https://openalex.org/W3127840351","https://openalex.org/W7215043942","https://openalex.org/W7154158393","https://openalex.org/W7158361163","https://openalex.org/W7166838688"],"abstract_inverted_index":{"BACKGROUND:":[0],"It":[1],"has":[2],"been":[3],"proposed":[4],"that":[5],"glucagon-like":[6],"peptide-1":[7],"receptor":[8],"(GLP-1R)":[9],"agonists":[10],"used":[11],"for":[12,82,259],"the":[13,29,34,133,143,159,180,213,230,246,253],"treatment":[14,195,258],"of":[15,33,47,67,123,179,201,245,274],"patients":[16,40,57,248,277],"with":[17,41,58,78,142,207,278,282],"type":[18],"2":[19],"diabetes":[20],"might":[21],"also":[22],"improve":[23],"their":[24],"psoriasis.":[25,43],"OBJECTIVE:":[26],"To":[27],"assess":[28],"efficacy":[30],"and":[31,63,94,107,288],"safety":[32],"GLP-1R":[35],"agonist":[36],"liraglutide":[37,79,134],"in":[38,92,105,128,132,154,177,197,212,243,250,270,290,295],"glucose-tolerant":[39,56,275],"plaque":[42,59,279],"METHODS:":[44],"A":[45,284],"total":[46],"20":[48],"obese":[49,276],"(body":[50],"mass":[51],"index":[52,65,98],">":[53],"25":[54],"kg/m(2)),":[55],"psoriasis":[60,280],"(psoriasis":[61],"area":[62],"severity":[64],"(PASI)":[66],"at":[68],"least":[69],"8)":[70],"were":[71,90],"randomized":[72],"1:1":[73],"to":[74],"once-daily":[75],"subcutaneous":[76],"injections":[77],"or":[80,268],"placebo":[81,144,214,254],"an":[83],"8-week":[84,231],"period.":[85,233],"The":[86,234],"primary":[87],"end":[88,101],"points":[89,102],"improvement":[91],"PASI":[93,129],"dermatology":[95],"life":[96],"quality":[97],"(DLQI).":[99],"Secondary":[100],"included":[103],"changes":[104],"weight":[106,286],"high":[108],"sensitive":[109],"C-reactive":[110],"protein":[111],"(hsCRP)":[112],"levels,":[113],"as":[114,116],"well":[115],"adverse":[117,226],"events.":[118],"RESULTS:":[119],"After":[120],"8":[121,260],"weeks":[122,261],"treatment,":[124],"no":[125],"significant":[126,285],"change":[127,176,265],"was":[130,156,238,293],"found":[131],"group":[135,145,215,273],"(mean\u00b1standard":[136],"deviation:":[137],"-2.6":[138],"\u00b1":[139,147,162,167,183,188,203,209],"2.1)":[140],"compared":[141,206,281],"(-1.3":[146],"2.4)":[148],"(P":[149,216],"=":[150,171,192,217],"0.228).":[151],"No":[152,224],"difference":[153],"DLQI":[155],"observed":[157,294],"between":[158],"groups":[160,181],"[-2.5":[161],"4.4":[163],"(liraglutide)":[164],"vs.":[165,186],"-3.7":[166],"4.8":[168],"(placebo);":[169],"P":[170,191],"0.564].":[172],"HsCRP":[173],"did":[174,262],"not":[175,263],"any":[178],"(0.26":[182],"1":[184],"(placebo)":[185],"0.25":[187],"2.2":[189],"(liraglutide);":[190],"0.992).":[193],"Liraglutide":[194,257],"resulted":[196],"a":[198,271],"bodyweight":[199],"loss":[200,287],"4.7":[202],"2.5":[204],"kg":[205,211],"1.6":[208],"2.7":[210],"0.014)":[218],"accompanied":[219],"by":[220],"decreased":[221],"cholesterol":[222,291],"levels.":[223],"serious":[225],"events":[227],"occurred":[228,242],"during":[229],"observation":[232],"most":[235],"common":[236],"complaint":[237],"transient":[239],"nausea,":[240],"which":[241],"45%":[244],"liraglutide-treated":[247,296],"but":[249],"none":[251],"from":[252],"group.":[255],"CONCLUSION:":[256],"significantly":[264],"PASI,":[266],"DLQI,":[267],"hsCRP":[269],"small":[272],"placebo.":[283],"decrease":[289],"levels":[292],"patients.":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2109769875","counts_by_year":[{"year":2026,"cited_by_count":24},{"year":2025,"cited_by_count":25},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
